Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Benzene and substituted derivatives
(total 20 related compounds in database, current show from 11 to 20)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
Compound 19R
(internal name in literature)		 Depiction based on curated SMILES O O Br OH O CH 3 O O Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
Compound 26
(internal name in literature)		 Depiction based on curated SMILES O O O O O H CH 3 Br CH 3 O O Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
Imidocarb Depiction based on curated SMILES O NH N NH N H NH N Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
4-(5-Bromosalicylideneamino)-N-(2-thiazolyl)benzenesulfonamide Depiction based on curated SMILES OH Br N O S N HN O S Escherichia TTSS (Type III secretion system) Preclinical (in vitro) Gauthier A, et al. 2005. Antimicrob Agents Chemother
(E)-N'-(2,3,4-Trihydroxybenzylidene)benzohydrazide Depiction based on curated SMILES OH OH O HO N N H Escherichia
Salmonella		 TTSS (Type III secretion system)
TTSS (SPI-1 encode); TTSS (SPI-2 encode)		 Preclinical (in vitro)
Preclinical (in vitro)		 Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem
Negrea A, et al. 2007. Antimicrob Agents Chemother
N'-[(E)-(2,4-dihydroxyphenyl)methylidene]-4-nitrobenzohydrazide Depiction based on curated SMILES _ O O + N O HO OH N N H Escherichia TTSS (Type III secretion system) Preclinical (in vitro) Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem
N'-(3,5-dichloro-2-hydroxybenzylidene)benzohydrazide Depiction based on curated SMILES OH Cl O Cl N N H Escherichia
Salmonella		 TTSS (Type III secretion system)
TTSS (SPI-1 encode); TTSS (SPI-2 encode)		 Preclinical (in vitro)
Preclinical (in vitro)		 Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem
Negrea A, et al. 2007. Antimicrob Agents Chemother
N-[3-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride Depiction based on curated SMILES HN ClH H 2 N N H N H 3 C O Escherichia Biofilm Preclinical (in vitro) Bunders CA, et al. 2010. Bioorg Med Chem Lett
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3,5-difluorobenzamide;hydrochloride Depiction based on curated SMILES N H ClH F F O H 2 N N H N Escherichia
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Bunders CA, et al. 2010. Bioorg Med Chem Lett
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride Depiction based on curated SMILES N H ClH H 2 N N H N CH 3 O Escherichia Biofilm Preclinical (in vitro) Bunders CA, et al. 2010. Bioorg Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2 



Back to top
2004-2025 NIPB, CAMS&PUMC